Last reviewed · How we verify
NCT06191822
Aspire2B Personalization Pilot Study Program
NA trial testing Nutrition in App Proficiency in 3,000 participants. Status unknown.
30 June 2024
Quick facts
| Lead sponsor | PepsiCo Global R&D |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 3,000 |
| Start date | 1 March 2022 |
| Primary completion | 30 June 2024 |
| Estimated completion | 30 June 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Nutrition
- Fitness
- Sleep
Conditions studied
- App Proficiency — all drugs for App Proficiency →
- Behavior — all drugs for Behavior →
- Lifestyle — all drugs for Lifestyle →
Sponsor
PepsiCo Global R&D — full company profile →
Who can join
Adults 18 to 75, any sex, with App Proficiency or Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This non-randomized pilot study program is focused on assessing the technical characteristics of the Aspire2B mobile device application.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06191822
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Nutrition
Trials testing the same drug.
- NCT06533345 — VCOM Pain Free Research Collaborative · NA · recruiting
- NCT06794931 — Study on the Impact of a Modified Mediterranean Diet, in Patients With Colorectal Cancer Undergoing Active Medical Oncol · NA · recruiting
- NCT05880992 — Trimodal Prehabilitation in Colorectal Cancer Patients · NA · recruiting
- NCT05752474 — Multi-Component Prehabilitation for Major Elective Surgery · NA · completed
- NCT05773469 — Energy Balance in Extreme Environments: Finding the EI Limit · completed
Other PepsiCo Global R&D trials
Trials by the same sponsor.
- NCT07429201 — Comparing an Electrolyte-Carbohydrate Beverage to Water During Ramadan · NA · completed
- NCT07400614 — Evaluating the Impact of Energy Drink Formulas on Alertness for an Extended Period · NA · recruiting
- NCT07427654 — Determination of the Glycemic Index of Products Varying in Levels of Refined and Whole Grain Corn · NA · completed
- NCT07298863 — The Effect of Hydration Status on Substrate Oxidation at Rest and During Light and Moderate Exercise · NA · recruiting
- NCT07217834 — Effects of a Glycerol-Electrolyte Beverage on Fluid Balance in Healthy Euhydrated Men and Women · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06191822 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by PepsiCo Global R&D
- Last refreshed: 5 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06191822.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing